Last reviewed · How we verify
A Study to Assess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, Including an Assessment of the Effects of Food on BMS-986172 Absorption
The purpose of this study is to evaluate the safety, tolerability and drug levels of BMS-986172 and evaluate the effects of food on BMS-986172 absorption.
Details
| Lead sponsor | Bristol-Myers Squibb |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 40 |
| Start date | Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy Participants
Interventions
- BMS-986172
- Placebo
Countries
United States